Sea You at Fetch Long Beach
|Videos|September 7, 2021

Advancements in testing for cancer in canines

Kansas City

Sue Ettinger, DVM, DACVIM (Oncology)—known as Dr Sue Cancer Vet—discusses recent advancements in cancer testing for canines. The highlights include 2 new low-cost, noninvasive tests.

In an interview at the Fetch dvm360® Conference in Kansas City, Sue Ettinger, DVM, DACVIM (Oncology)—known as Dr Sue Cancer Vet—discusses recent advancements in cancer testing for canines. The highlights include 2 new low-cost, noninvasive tests.

View the video for the entire discussion. The following is a partial transcript:

Sue Ettinger, DVM, DACVIM (Oncology): We used to have to do biopsies of the bladder or the prostate and now, just with a simple, free-catch urine test, we can find the cancer. And I also use the test to monitor the efficacy of my treatment as dogs are going through bladder cancer treatment or prostate cancer treatment.


Related to this article

Q&A: Caregiver burden can begin early in pet illness. Are veterinary teams equipped to support clients, and how can veterinary social workers help both parties?
Caroline Cox, LSW, MSW, and Erika Krick, VMD, DACVIM (Oncology), discuss the role of veterinary social workers in supporting clients, communicating with veterinary teams, and helping practices address the human side of veterinary care in this Q&A from an interview at the 2026 Fetch National Harbor Veterinary Conference.
Laverdia now available for purchase for dogs with lymphoma
Verdinexor tablets are now available for dogs with lymphoma after receiving full FDA approval earlier this year, offering an at-home treatment option given twice weekly and showing a longer time to disease progression than the control in a field study.